Litigation Details for Upsher-Smith Laboratories, LLC v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2021)
✉ Email this page to a colleague
Upsher-Smith Laboratories, LLC v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-08-04 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 28:1332 Diversity-Breach of Contract | Assigned To | |
| Jury Demand | None | Referred To | |
| Parties | CADILA HEALTHCARE LTD. | ||
| Patents | 10,363,224; 8,652,527; 8,889,190; 9,101,545; 9,555,005 | ||
| Attorneys | James T. Peterka | ||
| Firms | Phillips, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Upsher-Smith Laboratories, LLC v. Zydus Pharmaceuticals (USA) Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Upsher-Smith Laboratories, LLC v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-09-14 | 11 | Redacted Document | United States Patent Nos. 8,652,527, 8,889,190, 9,101,545, 9,555,005, and 10,363,224. A. The…(the “Patent Litigation Action”), against Zydus asserting infringement by Zydus of U.S. Patent Nos. 8,652,527…Asserted Patents and containing a “Paragraph IV” certification to each of the Asserted Patents. In an …prior to the expiration of the Asserted Patents and U.S. Patent No. 9,555,005, and also containing a Paragraph…each of the patents. USL filed an action against Glenmark alleging infringement of the patents | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
